Probiotics have consistently been shown to reduce liver enzyme levels (e.g., ALT, AST) in MASLD patients, but improvements in liver histology like inflammation, fibrosis, or steatosis have not been demonstrated in biopsy-confirmed settings. This evidence concerns the gene GPT and steatosis.